On June 11, 2025, Puma Biotechnology, Inc. held its annual meeting where stockholders elected eight directors, ratified KPMG LLP as independent accountants, and approved executive compensation. Notably, Alan H. Auerbach received 34,639,223 votes in favor, while the compensation proposal garnered 32,617,895 votes.